Wall Street analysts predict that Molina Healthcare, Inc. (NYSE:MOH) will post $4.27 billion in sales for the current quarter, Zacks reports. Five analysts have issued estimates for Molina Healthcare’s earnings. The lowest sales estimate is $4.25 billion and the highest is $4.30 billion. Molina Healthcare posted sales of $4.66 billion during the same quarter last year, which suggests a negative year over year growth rate of 8.4%. The company is scheduled to announce its next quarterly earnings results on Monday, February 10th.
On average, analysts expect that Molina Healthcare will report full year sales of $16.80 billion for the current year, with estimates ranging from $16.69 billion to $16.86 billion. For the next financial year, analysts expect that the business will post sales of $17.91 billion, with estimates ranging from $17.43 billion to $18.39 billion. Zacks’ sales averages are a mean average based on a survey of sell-side analysts that cover Molina Healthcare.
Molina Healthcare (NYSE:MOH) last announced its quarterly earnings results on Tuesday, October 29th. The company reported $2.80 EPS for the quarter, beating the Zacks’ consensus estimate of $2.70 by $0.10. Molina Healthcare had a net margin of 4.47% and a return on equity of 49.14%. The firm had revenue of $4.24 billion during the quarter, compared to the consensus estimate of $4.15 billion. During the same quarter last year, the firm earned $2.97 EPS. The firm’s revenue for the quarter was down 9.7% compared to the same quarter last year.
Several equities analysts have recently weighed in on MOH shares. Jefferies Financial Group downgraded Molina Healthcare from a “buy” rating to a “hold” rating and cut their target price for the company from $133.00 to $120.00 in a research report on Wednesday, October 30th. ValuEngine upgraded Molina Healthcare from a “sell” rating to a “hold” rating in a research report on Friday, November 29th. Deutsche Bank initiated coverage on shares of Molina Healthcare in a research note on Thursday, September 12th. They set a “buy” rating and a $145.00 price objective for the company. Finally, Morgan Stanley cut their price objective on shares of Molina Healthcare from $184.00 to $172.00 and set an “overweight” rating on the stock in a research report on Friday, August 23rd. One investment analyst has rated the stock with a sell rating, six have issued a hold rating and six have assigned a buy rating to the stock. The stock presently has a consensus rating of “Hold” and a consensus price target of $155.89.
In related news, Director Ronna Romney sold 375 shares of the business’s stock in a transaction that occurred on Friday, November 8th. The stock was sold at an average price of $121.97, for a total value of $45,738.75. The sale was disclosed in a document filed with the Securities & Exchange Commission, which is available at this hyperlink. Also, Director Dale B. Wolf sold 3,500 shares of the stock in a transaction that occurred on Monday, December 2nd. The stock was sold at an average price of $135.51, for a total value of $474,285.00. Following the completion of the transaction, the director now directly owns 8,461 shares in the company, valued at approximately $1,146,550.11. The disclosure for this sale can be found here. Corporate insiders own 0.77% of the company’s stock.
A number of institutional investors and hedge funds have recently added to or reduced their stakes in MOH. Nuveen Asset Management LLC purchased a new position in shares of Molina Healthcare in the 2nd quarter worth approximately $102,187,000. Boston Partners purchased a new stake in shares of Molina Healthcare during the 2nd quarter valued at $82,898,000. AQR Capital Management LLC lifted its holdings in shares of Molina Healthcare by 31.7% during the 2nd quarter. AQR Capital Management LLC now owns 954,433 shares of the company’s stock valued at $133,945,000 after purchasing an additional 229,987 shares during the last quarter. Massachusetts Financial Services Co. MA grew its stake in Molina Healthcare by 294.0% during the 3rd quarter. Massachusetts Financial Services Co. MA now owns 198,457 shares of the company’s stock worth $21,776,000 after buying an additional 148,085 shares during the last quarter. Finally, Renaissance Technologies LLC increased its position in Molina Healthcare by 3.7% during the 2nd quarter. Renaissance Technologies LLC now owns 3,831,905 shares of the company’s stock valued at $548,499,000 after buying an additional 136,700 shares in the last quarter. Institutional investors own 95.85% of the company’s stock.
Shares of NYSE:MOH traded up $0.81 during trading on Thursday, hitting $133.30. The company had a trading volume of 408,700 shares, compared to its average volume of 471,579. The stock has a market cap of $8.31 billion, a price-to-earnings ratio of 12.03, a price-to-earnings-growth ratio of 1.22 and a beta of 1.16. Molina Healthcare has a one year low of $105.28 and a one year high of $159.00. The company has a fifty day simple moving average of $127.53 and a two-hundred day simple moving average of $130.84. The company has a debt-to-equity ratio of 0.80, a current ratio of 1.78 and a quick ratio of 1.78.
About Molina Healthcare
Molina Healthcare, Inc provides Medicaid-related solutions to meet the health care needs of low-income families and individuals; and to assist state agencies in their administration of the Medicaid program in the United States. It operates through three segments: Health Plans, Molina Medicaid Solutions, and Other.
See Also: What is quantitative easing?
Get a free copy of the Zacks research report on Molina Healthcare (MOH)
For more information about research offerings from Zacks Investment Research, visit Zacks.com
Receive News & Ratings for Molina Healthcare Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Molina Healthcare and related companies with MarketBeat.com's FREE daily email newsletter.